Patents by Inventor Nabil Alkayed

Nabil Alkayed has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTAGONISTS OF GPR39 PROTEIN
    Publication number: 20230174484
    Abstract: Novel compounds that act as antagonists to human GPR39 protein are disclosed. Pharmaceutical compositions and methods of use for antagonists to human GPR39 protein are disclosed. In particular, methods of using the antagonists in the treatment of diseases or conditions including cardiovascular conditions, endocrine system and hormone disorders, cancer disorders, metabolic diseases, gastrointestinal and liver diseases, hematological disorders, neurological disorders and respiratory diseases are disclosed herein.
    Type: Application
    Filed: April 30, 2021
    Publication date: June 8, 2023
    Inventors: Sanjiv KAUL, Nabil ALKAYED, Shanthi NAGARAJAN, Agostino CIANCIULLI, Fabrizio MICHELI, Teresa SEMERARO, Iuni Margaret Laura TRIST
  • TREATMENT OF ISCHEMIC STROKE WITH DRa1-MOG-35-55
    Publication number: 20150099706
    Abstract: Methods and compositions used in treating ischemic stroke using a recombinant DR?-MOG-35-55 construct are disclosed. The disclosed methods involve administering a pharmaceutical composition comprising DR?-MOG-35-55 and a pharmaceutically acceptable carrier to a subject that has had or is at risk of developing ischemic stroke.
    Type: Application
    Filed: October 3, 2014
    Publication date: April 9, 2015
    Inventors: Halina Offner-Vandenbark, Nabil Alkayed, Arthur A. Vandenbark